Diversity of greek meningococcal serogroup B isolates and estimated coverage of the 4CMenB meningococcal vaccine

BACKGROUND: Serogroup B meningococcal (MenB) isolates currently account for approximately 90% of invasive meningococcal disease (IMD) in Greece with ST-162 clonal complex predominating. The potential of a multicomponent meningococcal B vaccine (4CMenB) recently licensed in Europe was investigated in...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Tzanakaki, Georgina, Hong, Eva, Kesanopoulos, Konstatinos, Xirogianni, Athanasia, Bambini, Stefania, Orlandi, Luca, Comanducci, Maurizio, Muzzi, Alessandro, Taha, Muhamed-Kheir
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2014
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4018652/
https://ncbi.nlm.nih.gov/pubmed/24779381
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2180-14-111
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak